October 21, 2025
Specialty drug access challenges go beyond cost and paperwork. In Pharmaceutical Commerce, CoverMyMeds’ Megan Wetzel and Pleio’s Jen Butler discuss how prior authorization delays, affordability barriers, and patient loneliness together undermine adherence—and why restoring connection is key to better outcomes.
October 28, 2025
In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.
October 1, 2025
Pleio CEO Michael Oleksiw appears on Planetary Health First, Mars Next to explore how tackling loneliness is key to better health outcomes. He reveals how Pleio’s human-first approach helps patients stay on therapy by addressing emotional barriers that technology alone can’t solve.
September 24, 2025
As part of Fierce Pharma Marketing’s Rising Stars series, Pleio Marketing Manager Madison Norman discusses why empathy should lead the way in health tech. She explores how balancing innovation with human understanding can drive more meaningful patient experiences.
September 16, 2025
Healthcare, like baseball, is ultimately a human experience. No matter how advanced the tools, patients still want to feel something real: that someone sees them, hears them, and cares. Pleio CEO Michael Oleksiw writes that the future of healthcare isn’t about replacing people with technology, but blending the two to deliver precision and compassion.
August 26, 2025
Specialty pharmacies are turning to AI to improve medication adherence. AI tools like OLLIE help to analyze patient conversations for emotional and behavioral cues, helping providers address why patients skip prescriptions and strengthening support for chronic care management.
FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.